Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novartis AG (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVS
New York
2834
https://www.novartis.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novartis AG (ADR)
Novartis Stock Jumps After Beating Expectations, Raising Guidance
- Apr 23rd, 2024 3:32 pm
Novartis Ag (NVS) Q1 2024 Earnings Call Transcript
- Apr 23rd, 2024 3:15 pm
Novartis raises full-year guidance on Q1 beat, drug sales
- Apr 23rd, 2024 2:51 pm
How Novartis Rode Two Blockbuster Drugs To Its Beat And Raise, And Three-Day Sprint
- Apr 23rd, 2024 2:23 pm
Incyte (INCY) to Report Q1 Earnings: What's in the Cards?
- Apr 23rd, 2024 1:44 pm
Compared to Estimates, Novartis (NVS) Q1 Earnings: A Look at Key Metrics
- Apr 23rd, 2024 1:30 pm
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
- Apr 23rd, 2024 1:00 pm
The Zacks Analyst Blog Highlights Novartis, American Express, ConocoPhillips, Netflix and Schlumberger
- Apr 23rd, 2024 12:57 pm
Health Care Roundup: Market Talk
- Apr 23rd, 2024 12:19 pm
Former Bristol Myers CEO tapped as Novartis’ next board chair
- Apr 23rd, 2024 12:02 pm
Novartis raises forecasts as top drug sales beat Wall Street estimates
- Apr 23rd, 2024 11:45 am
Trending tickers: Tesla, ABF, Novartis, Taylor Wimpey, JD Sports
- Apr 23rd, 2024 9:12 am
UPDATE 1-Healthcare, tech stocks boost STOXX 600 to one-week high
- Apr 23rd, 2024 8:58 am
Novartis Raises Guidance on Profit, Sales Growth
- Apr 23rd, 2024 8:08 am
Techs boost STOXX to one-week high; euro zone data on tap
- Apr 23rd, 2024 7:01 am
UPDATE 4-Novartis raises guidance after beating Q1 expectations
- Apr 23rd, 2024 5:18 am
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
- Apr 23rd, 2024 5:00 am
Top Analyst Reports for Novartis, American Express & ConocoPhillips
- Apr 22nd, 2024 5:17 pm
Novartis (NVS) to Report Q1 Earnings: What to Expect?
- Apr 19th, 2024 2:10 pm
US FDA mandates label updates on CAR-T cancer therapies
- Apr 18th, 2024 10:33 pm
Scroll